DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8762ba/orphan_autoimmune) has announced the addition of the "Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market" report to their offering.
GBI Research, the leading business intelligence provider, has released its latest research, Orphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP Market. It provides in-depth analysis of the drivers and barriers that affect the global orphan autoimmune disorders therapeutics market. The report analyzes the markets for orphan autoimmune disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2017 for the key geographies as well as the leading therapeutic segments (ITP, myasthenia gravis and ALS). Furthermore, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
The Global Orphan Autoimmune Disorder Therapeutics Market Will Grow Steadily with Very Few Promising Molecules in the Pipeline
The orphan autoimmune disorder therapeutics market is one of the steadily growing markets in autoimmune therapeutics and is expected to show a significant growth in forecast period. The ITP and ALS market are the leading contributors to the global orphan autoimmune disorder therapeutics market in 2010. Moreover, the market for myasthenia gravis has shown a steady growth in terms of revenue and is expected to grow at a greater pace in the future.
Read more inside Orphan Autoimmune Disorders to 2017
Companies Mentioned:
- Amgen Inc.
- GlaxoSmithKline
- CSL Behring LLC
- Mitsubishi Tanabe Pharma Corporation
- Biogen Idec
For more information visit http://www.researchandmarkets.com/research/8762ba/orphan_autoimmune